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The phenomenon of the susceptibility and reversion of resistance to antibiotics in strains of bacteria and 
yeast-like molds has been identified upon the interaction of bacteria and molds with transplantable human 
and animal cell lines depending on the cultivation conditions. The ability of susceptibility reversion of 
bacteria and yeast-like fungi to some antibiotics is not stable, it varies with the passages. This phenomenon 
may be a reason of the poor efficacy of antibiotic treatment when the susceptibility of bacteria to antibiotics 
is assayed by the usual technique. The authors propose to modify the antibiotics-susceptibility assay 
currently used in clinics by co-culture of the isolated bacteria and fungi with the transplantable cell lines 
or human leukocytes. 
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Introduction. Bacterial and yeast-like organisms are 
usually isolated using nutrient media; the same media 
are taken to verify the antibiotic resistance of these 
microorganisms. However, a lot of different strains of 
bacteria and yeast-like organisms are parasites in­
habiting different human and animal organs con­
sisting of different type cells (epithelium-like, fib-
roblast-like, etc.). There are some published data [1 ] 
describing the adhesion process properties during 
shigellae interactions with human embryo intestinal 
mucosa. 
Bacteria colonize the biomaterial, thereby adop­
ting a sessile mode of growth that progresses to the 
establishment of an antibiotic-resistant biofilm by the 
accretion of prospective glycocalyx [2, 3 ] . Amino-
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glycosides, quinolones, beta-lactams, and polymixins 
require crossing the bacterial cell wall to reach their 
targets. Penetration can be reduced by the develop­
ment of antibiotics-resistant biofilms with secretion of 
an anionic exopolysaccaride matrix with binds ca-
tionic antibiotic [6 ]; quorum sensing in such biofilms 
may also be involved in changing bacterial metabolism 
and reducing sensitivity to antimicrobials [4—61. 
Due to this fact, we became interested in the 
cultivation of bacteria and yeast-like organisms in 
cells of humans and animals of different species as 
well as in host-parasite cell interactions and in the 
antibiotic susceptibility of infectious agents. 
Materials and Methods. Strains of microorga­
nisms. In this investigation, we used the following 
strains isolated previously in our laboratory: 9 Staphy­
lococcus aureus strains and 2 Staph, epidermidis ones 
(gram-positive bacteria); 7 Pseudomonas aeruginosa 
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strains and 22 different Enterococcus strains (gram-
negative bacteria); 17 representatives of the Candida 
genus and 2 Cryptococcus neoformans strains. Estab­
lished cell lines taken for these studies were: L41 
(human lymphoblastoid cell line), OH-1 (murine 
lymphoblastoid cell line), RGNR (cell line originated 
from rat Gasser node neurinoma), and Vero (green 
African monkey kidney cell line). Cell cultures were 
grown in the RPMI-1640 supplemented both with calf 
foetal serum (10 %) and antibiotics [7 ] . 
We also manipulated with human leukocyte sus­
pension cultures (blood group 0) . The cultivation of 
bacterial strains was performed as follows: 100 /Л of 
bacterial suspension containing 1-Ю 8 cells were ad­
ded to a leukocyte culture (3 -Ю 6 cel ls /ml) . Following 
bacterial growth during 24 h, 100 /Л of infected 
leukocyte suspension of the same concentration were 
transferred into a new leukocyte culture to carry out 
the 2 n d passage. The 3 r d one was made similarly. 
Antibiotic sensitivity of bacterial cultures for each 
passage was studied and compared with its original 
sensitivity to antibiotics. In these experiments we 
used two interferon (IFN) preparations — IFN-a-2b 
(Intron, 3 -Ю 6 I. U., Shering-Plau, USA), and IFN-y 
(10 ъ I. U., product of the Ukrainian Academy of 
Agriculture). 
Cultivation of bacteria and fungi. Each microbial 
or fungal strain was grown in cultured 24 h-old 
monolayer cell lines or in suspended human leuko­
cytes. 
Each microbial/fungal suspension (10 8 cells/ml) 
was put into cell cultures or human leukocyte sus­
pension and cultivated during 24 h in RPMI-1640 
without calf foetal serum and antibiotics. The degree 
of susceptibility of microbial/fungal strains to anti­
biotics was determined before their growth in euka-
ryotic cells grown in the Mueller-Hinton medium 
(initial susceptibility, IS) and following their culti­
vation (post-cultivation susceptibility, PCS). 
The antibiotic susceptibility was evaluated by the 
Bauer-Kirby approach (a variant of the disk-diffusion 
method) [8]; all bacterial/fungal strains were grown 
on the Mueller-Hinton medium; commercial disks 
used were produced by the (St. Petersburg, Russian 
Federation). The disk quality control with the Muel­
ler-Hinton medium and different antibiotics was per­
formed each time as well as with any new disk series 
of nutrient media series. The criteria of their ade­
quacy were verified according to the zone diameter of 
inhibited growth for etalon strains — Escherichia coli 
25922, S. aureus ATCC 25923, and P. aeruginosa 
ATCC 27853 received from the Alive Culture Museum 
of our Institute. 
The manufacturer's criteria were used to evaluate 
the efficacy of antibiotics against microbial/fungal 
agents. Taking into consideration the zone diameter 
of inhibited growth for investigated microorganisms, 
the strains were divided into three groups — sus­
ceptible strains (SS), moderately resistant strains 
(MRS), and strains highly resistant to antibiotic(s) 
(HRS) [ 9 ] . We determined antibiotic-susceptib­
le/resistant properties of strains with the following 
compounds widely used in up-to-date clinical practice: 
Enterobacteriaceae susceptibility to antibiotics are 
given in Table 1. 
The analysis of the data presented in Table 1 
shows that the Enterobacteriaceae cultivation in the 
L41 cell line causes the development of two phe-
notypes: some antibiotic-sensitive strains become re­
sistant ones and vice versa. This Table proves the 
enterobacterial strains have not changed their sus­
ceptibility to gentamicin, cefoperazone, and imipe-
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Table 1 
Antibiotic susceptibility of enterobacterial strains grown in the L41 culture during 24 h 
Antibiotic (the zone diameter, mm, of inhibited growth for etalon strains) 
cip cpr 
N o t e . Bold figures indicate the change of strain susceptibility to antibiotics. 
nem. Some changes of antibiotic sensitivity were 
found in 14 enterobacterial strains, resistant strains 
becoming sensitive ones and vice versa. 
The Enterobacteriaceae changes from resistance 
to susceptibility (R -* S) were found for the following 
antibiotics: amikacin (for one strain), cefazolin (for 
three strains), and tobramicin (for 1 strain). 
Another variability type — from susceptibility to 
resistance (S -> R) — was shown for the following 
antibiotics: amikacin (3 strains), chloramphenicol (1 
strain), ciprofloxacin (3 strains), cefotaxime (2 stra­
ins), cefazolin (1 strain), ceftriaxone (2 strains), 
ceftazidime (3 strains), amoxicillin/clavulanic acid (3 
strains). The enterobacterial variability index (S -» R) 
is very important for patients' treatment, since any 
non-adequately chosen antibiotic does not promote 
successful therapy results. 
Moderately susceptible enterobacterial strains de­
monstrate also the variability phenomenon becoming 
more resistant; at the same time, some susceptible 
strains of this bacterial group become moderately 
susceptible. 
The data described above demonstrate the ente­
robacterial transition from to antibiotics susceptibility 
to antibacterial resistance and vice versa in the L41 
cell line. We aimed to verify whether such phe­
nomenon is ubiquitous enough and if it may be found 
also during Enterobacteriaceae cultivation in cell lines 
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Fig. 1. Sensitivity changes (%) to antibiotics (7—70) 
following Enterobacteriaceae passages in RGNR cells: 
7 — stable; 2 — unstable; 3 — amk; 4 — amp; 5 — 
chl; 6 — cip; 7 — kf; 8 — caz; 9 — его; ю — ctx 
15,8 
Fig. 2. Sensitivity changes (%) to antibiotics (7—70) 
following Enterobacteriaceae passages in Vero cells: 
7 — stable; 2 — unstable; 3 — amx; 4 — amk; 5 — 
caz; 6 — ctx; 7 — kf; 8 — cip; 9 — его; 70 — ctx 
of other origin; so we used several of the above-
mentioned cell lines for their growth — RGNR (Fig. 
1), Vero (Fig. 2) , OH-1 (Fig. 3) , and L41 (Fig. 4). 
The analysis of the data presented proves the 
Enterobacteriaceae susceptibility to different antibio­
tic compounds does not depend on donor animal 
species used as primary culture. Seven enterobacterial 
strains changed their susceptibility/resistance follo­
wing 24 h of their co-cultivation with eukaryotic cell, 
giving rise to both transitions — (S -> R) and (R -» 
-> S). Cultivation of our strains in other four different 
cell lines revealed the same phenomenon. 
The next step of our investigations was the 
susceptibility determination of a gram-positive bac­
terium, S . aureus у during its growth in the cell line 
L41. Analyzing these results, it should be noted that 
the antibiotic susceptibility profile changed only for a 
single S. aureus strain; the (S R) transition was 
found for such antibiotic compounds as oxacillin, 
clindamycin, and cefazolin. 
The data concerning the antibiotic susceptibility 
changes for yeast-like fungi (Candida genus repre­
sentatives and Cr. neoformans) are shown in Fig. 5. 
The data obtained show that the (S -> R) and (R -» 
-» S) transitions are found in seven Candida strains 
among 17 studied. The (R -> S) transition was de­
tected for anti-Candida drugs: fluconazole (in 4 
strains) and clotrimazole (in 2 strains). The transition 
(S R) was found for amphotericin В (in 5 strains), 
fluconazole (in 1 strain), and clotrimazole (in 1 
strain). 
Among two Cr. neoformans strains studied here, 
the (R -> S) transition for fluconazole was registered 
for a single strain. 
These data indicate that the interactions between 
cultivated eukaryotic cells and parasitic ones including 
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Fig. 3. Sensitivity changes (%) to antibiotics (1—13) 
following Enterobacteriaceae passages in OH-1 cells: 
/ — stable; 2 — unstable; 3 — amp; 4 — amk; 5 — 
amx; 6 — ctx; 7 — tet; 8 — caz; 9 — tob; 10 — cip; 
11 — его; 12 — chl; 13 — kf 
gram-positive and gram-negative bacteria as well as 
yeast-like microorganisms cause both (S R) and 
(R -> S) transitions. It leads to the conclusion the 
results of parasitic organism testing in nutrient media 
aimed at the determination of its susceptibility to 
antibiotics does not always reflect real antimicrobial 
effect in animal and human organisms, this situation 
being probably due to biofilm development on the 
monolayer surface. Therefore, we realized a series of 
experiments to determine the susceptibility of para­
sitic microorganisms in donor blood leukocytes, three 
passages of each microorganism studied having been 
carried out. We have found antibiotic susceptibility 
Changes for different Strains Of ЕгІІЄГОииСІЄҐІйСЄйЄ, S. 
aureus, S. epidermidis, P. aeruginosa, C. albicans, 
and Cr. neoformans during their 2 n d — 3 r d passages in 
human leukocytes. 
Our comparative analysis of susceptibility to 
Fig. 4. Sensitivity changes (%) to antibiotics (1—13) 
following Enterobacteriaceae passages in L41 cells: 
I — stable; 2 — unstable; 3 — amk; 4 — amp; 5 — 
kf; 6 — tet; 7 — caz; 8 — tob; 9 — amx; 10 — chl; 
II — cro; 12 — cip; 13 — ctx 
antibiotics in gram-positive and gram-negative bac­
teria as well as in yeast-like parasites during their 
passages through cultured human leukocytes shows 
the susceptibility changes; usually such changes are 
detected more often in gram-negative bacteria and 
yeast-like fungi. 
Among 15 enterobacterial strains the suscep­
tibility changes were registered in 12 ones. The (S -» 
-> R) transitions were seen with such antibiotics as 
ciprofloxacin (for 1 strain), tetracycline (for 3 stra­
ins), and amikacin (for 1 strain). The (R -» S) 
changes were registered for tobramycin (3 strains), 
ciprofloxacin (1 strain), amoxicillin/clavulanic acid (2 
strains), ceftazidime (2 strains), ceftriaxone ( І stra­
in) . The changes of MRS -» HRS type were detected 
for cefazolin (2 strains), ciprofloxacin (2 strains), and 
amoxicillin/clavulanic acid (1 strain). The transition 
MRS SS was found for tobramycin (in 1 strain), 
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Fig. 5. Sensitivity changes (%) to antibiotics (1—3) 
following Candida and Cryptococcus passages in 
cultivated cells: 1 — flu; 2 — clo; 3 — araph 
amoxicillin/clavulanic acid (in 1 strain), and cefepime 
(in 1 strain). Only two ciprofloxacin-susceptible stra­
ins show the changes from SS to MRS phenotype. 
The enterobacterial transitions from SS to resis­
tant phenotype during the 2 n d — 3 r d passages in human 
leukocytes occur in 80 % of strains tested; they 
became resistant to tobramycin, ciprofloxacin, amo­
xicillin/clavulanic acid, ceftazidime, ceftriaxone, cefa­
zolin, cefepime, and amikacin. The same bacteria 
keep their susceptibility unchanged as well as their 
resistance to ampicillin, gentamicin, and imipenem. 
The data concerning the changes of P. aeruginosa 
susceptibility/resistance during the passages through 
human leukocytes show such changes in three strains 
among five ones. The transition from SS- to MRS-
phenotype was found for amikacin (2 strains) and 
netilmicin (1 strain). One strain susceptible to cipro­
floxacin became resistant to this drug. The second P. 
aeruginosa strain with moderate resistance to cefo­
perazone lost this property becoming a susceptible 
strain. The third strain of high anti-amikacin resis­
tance obtained a moderate resistant phenotype. One 
P. aeruginosa strain demonstrated unstable resistance 
to carbenicillin. 
The susceptibility/resistance of P. aeruginosa 
strains concerning such antibiotics as gentamicin, 
imipenem, cefepime, azlocillin, and ceftazidime show 
no changes. 
The passages of Candida genus representatives 
in human leukocyte cultures demonstrate often un­
stable type resistance against some antibiotics: fluco­
nazole (in 2 strains), clotrimazole and amphotericin В 
(in 1 strain); in addition, one Candida strain shows 
the HRS -» MRS transition. Stable susceptibility to 
nystatin was found for all Candida strains used in our 
investigations. 
Similar results were obtained with two Cr. neo-
formans strains being constantly susceptible to nys­
tatin during three passages. At the same time these 
passages sometimes lead to the resistance develop­
ment in susceptible strains: one strain became resis­
tant against clotrimazole and amphotericin B, another 
strain developed a fluconazole-resistant phenotype. 
Two species of gram-positive bacteria — S. au­
reus (1 strain) and S. epidermidis (2 strains) —are 
less variable, the only transition (from higher to 
lower) was found for ciprofloxacin resistance. 
It is evident that the changes in antibiotic sus­
ceptibility of different microorganisms appear follo­
wing their passages through several cell lines of 
different species origin as well as through human 
leukocyte cultures. If the microorganisms change their 
susceptibility to certain antibiotics during passages, it 
is clear such drugs are not adequate for clinical 
practice use. Special attention should be paid to 
susceptibility changes in Enterobacteriaceae strains, 
P. aeruginosa, yeast-like organisms being susceptible 
to antibiotics chosen following the Bauer-Kirby test. 
Such changes may result in insufficient treatment 
results in clinical use. We found several antibiotics 
being continuously effective against Enterobacteria­
ceae and P. aeruginosa — ampicillin, gentamicin, and 
imipenem. 
The yeast-like microorganisms belonging to Can­
dida and Cr. neoformans change also their suscep­
tibility to some antibiotics including fluconazole, clo­
trimazole, and amphotericin B, their susceptibility to 
nystatin being kept without changes. 
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Table 2 
Determination of enterobacterial strain 1646 susceptibility to antibiotics and its resistance to antibiotics during its growth in the L41 
established cell line (24 h) 
Antibiotic (the zone diameter, mm, of inhibited growth for etalon strains) 
The changes of microorganism susceptibility to 
antibiotics are due to numerous factors including 
properties of bacteria/yeast-like agents, properties of 
their host cells, culture media with all their com­
ponents, and metabolic products. The unstable results 
obtained in our investigations and their changes 
during the passages carried out led us to a hypothesis 
concerning the metabolic products as the main varia­
bility factor. To verify this hypothesis, we carried out 
the following experiment in a model system using an 
enterobacterial strain, 1646, with multiple changes of 
susceptibility to antibiotics. The bacteria were grown 
in: 
1. L41 cell culture washed carefully from its 
culture medium before bacterial infecting (cell cul­
ture, CC); 
2. Medium following the L41 cell line cultivation 
(medium post cell cultivation, MCC); 
3. RPMI-1640 (cell medium, original, CMO). 
The results obtained are presented in Table 2. They 
show the susceptibility changes to occur in the MCC 
containing cell metabolic products including also cyto­
kines, e. g. IFN. 
Due to these data, a question arose about pos­
sible IFN participation in changes of antibiotic sus­
ceptibility for different microorganisms. To answer 
this question, we carried out some additional re­
searches. The L41 cells were pre-treated by recom­
binant IFN preparations, IFN-a-2b, or by an IFN-y 
preparation (see above; both preparations contained 
10 5 I. U.) (10 8 bacterial cel ls /ml) . The results obtai­
ned are given in Table 3. 
The data presented in Table 3 show that during 
two strains (724, 396) strains cultivation in L41 cell 
line, they change their susceptibility to antibiotics, 
the susceptible bacteria becoming resistant to amo­
xicillin/clavulanic acid, cefotaxime, ciprofloxacin, cef­
triaxone, and ceftazidime. The IFN-a-2b exerts no 
influence on susceptibility changes. 
The results obtained in the experiments with the 
IFN-y preparation concerning its effect on the strains 
724 and 396 susceptibility/resistance suggest this 
cytokine to promote the R -» S transition for ami­
kacin, cefotaxime, ciprofloxacin, ceftriaxone, and ce-
fazolin. 
Similar results were obtained while cultivating 
Enterococcus faecalis in human neutrophils with 
gamma-IFN (1) and Listeria monocytogenes in mac­
rophages with the same cytokine (2). 
All these data allow the conclusion that the 
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Bauer-Kirby test as well as other similar tests using 
bacterial nutrient media do not give information 
sufficient for therapeutic schema elaboration including 
antibiotic use in vivo. They need additional correction 
to determine real antibiotic susceptibility for different 
infectious agents. The cell-produced IFNs may exert 
their effect on bacteria ability to change their anti­
biotic susceptibility. 
С. Л. Рибалко, О. В. Покас, В. А. Дєєв, Т. Ы. Лясковський, 
Т. М. Фурзікова, С. Т. Дядюн, Н. В. Іванська, Н. I. Настояща, 
П. П. Верхацький, С. Т. Сальков 
Зміна чутливості до антибіотиків штамів бактерій і грибів при 
культивуваннні їх у перещеплюваних культурах клітин людини 
і тварин 
Резюме 
При взаємодії бактерій і грибів з клітинами людини та 
тварин ідентифіковано феномен реверсії чутливості та рези­
стентності до антибіотиків бактерій і грибів. Властивість 
реверсії чутливості бактерій і грибів до деяких антибіотиків 
нестабільна, вона змінюється від пасажу до пасажу, що може 
обумовлювати неефективність лікування антибіотиками при 
чинних методах встановлення чутливості до антибіотиків 
бактерій і грибів. Автори пропонують модифікувати тест 
антибіотикочутливості бактерій і грибів, виділених на по­
живних середовищах, культивуванням їх у культурі перещеп­
люваних клітин або лейкоцитах людини. 
Ключові слова: антибіотики, клітини, ентеробактерії, ре­
зистентність. 
С. Л. Рыбалко, Е. В. Покас, В. А. Деев, Т. М. Лясковский, 
Т. М. Фурзикова, С. Т. Дядюн, Н. В. Иванская, 
Н. И. Настоящая, П. П. Верхацкий, С. Т. Сальков 
Изменение устойчивости к антибиотикам штаммов бактерий 
и дрожжеподобных грибов при культивировании их в 
перевиваемых культурах тканей человека и животных 
Резюме 
При взаимодействии бактерий и грибов с клетками человека 
и животных идентифицирован феномен реверсии чувствитель­
ности и резистентности к антибиотикам бактерий и грибов 
в зависимости от условий выращивания. Свойство реверсии 
чувствительности бактерий и грибов к некоторым антибио­
тикам нестабильно, оно изменяется от пассажа к пассажу, 
что может обусловливать неэффективность лечения антиби­
отиками при существующем методе определения чувстви­
тельности к антибиотикам бактерий и грибов. Авторы пред­
лагают модифицировать тест антибиотикочувствительно-
сти бактерий и грибов, выделенных на питательных средах, 
культивированием их в культуре перевиваемых клеток или 
лейкоцитах человека. 
Ключевые слова: антибиотики, клетки, энтеробактерии, 
резистентность. 
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